1Goulis J,Leandro G,Burroughs AK.Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis:a meta-analysis.Lancet,1999,25:1053-1060.
2Combes B,Luketic VA,Peters MG,et al.Prolonged follow-up of patients in the U.S.multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.Am J Gastroenterol,2004,99:264-268.
3Poupon RE,Bonnard A,Chretien Y,et al.Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis.Hepatology,1999,29:1668-1671.
4Corpechot C,Carrat F,Bahr A,et al.The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.Gastroenterology,2005,128:297-303.
5Hempfling W,Dilger K,Beuers U.Systematic review:ursodeoxycholic acid-adverse effects and drug interactions.Aliment Pharmacol Ther,2003,18:963-972.
6Angulo P,Jorgensen RA,Lindor KD.Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis:is a double dosage worthwhile? Am J Gastroenterol,2001,96:3152-3157.
8Heathcote EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines.Hepatology,2000,31:1005-1013.
9Lazaridis KN,Gores GJ,Lindor KD.Ursodeoxycholic acid 'mechanism of action and clinical use in hepatobiliary disorders'.J Hepatol,2001,35:134-146.
10Paumgartner G,Beuers U.Ursodeoxycholic acid in cholestatic liver disease:mechanism of action and therapeutic use revisited.Hepatology,2002,36:525-531.
